;PMID: 11376557
;source_file_713.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..38] = [t:0..38]
;1)sentence:[e:43..133] = [t:43..133]
;2)section:[e:137..201] = [t:137..201]
;3)section:[e:205..332] = [t:205..332]
;4)sentence:[e:336..473] = [t:336..473]
;5)sentence:[e:474..770] = [t:474..770]
;6)sentence:[e:771..1117] = [t:771..1117]
;7)sentence:[e:1118..1276] = [t:1118..1276]
;8)sentence:[e:1277..1385] = [t:1277..1385]
;9)sentence:[e:1386..1514] = [t:1386..1514]
;10)sentence:[e:1515..1742] = [t:1515..1742]
;11)section:[e:1746..1791] = [t:1746..1791]

;section 0 Span:0..38
;Jpn J Cancer Res  2001 May;92(5):494-8
(SEC
  (FRAG (NNP:[0..3] Jpn) (NNP:[4..5] J) (NNP:[6..12] Cancer) (NNP:[13..16] Res)
        (CD:[18..22] 2001) (CC:[23..30] May;92-LRB-) (CD:[30..31] 5)
        (-RRB-:[31..32] -RRB-) (CD:[32..36] :494) (::[36..37] -) (CD:[37..38] 8)))

;sentence 1 Span:43..133
;Mutations in c-kit gene exons 9 and 13 in gastrointestinal stromal tumors
;among  Japanese.
;[43..52]:variation-event:"Mutations"
;[56..61]:gene-rna:"c-kit"
;[67..74]:variation-location:"exons 9"
;[67..72]...[79..81]:variation-location:"exons"..."13"
;[85..116]:malignancy:"gastrointestinal stromal tumors"
(SENT
  (NP-HLN
    (NP (NNS:[43..52] Mutations))
    (PP-LOC (IN:[53..55] in)
      (NP
        (NP (NN:[56..61] c-kit) (NN:[62..66] gene))
        (NML
          (NML
            (NML-1 (NNS:[67..72] exons))
            (CD:[73..74] 9))
          (CC:[75..78] and)
          (NML
            (NML-1 (-NONE-:[78..78] *P*))
            (CD:[79..81] 13)))))
    (PP-LOC (IN:[82..84] in)
      (NP (JJ:[85..101] gastrointestinal) (JJ:[102..109] stromal)
          (NNS:[110..116] tumors)))
    (PP (IN:[117..122] among)
      (NP (NNPS:[124..132] Japanese)))
    (.:[132..133] .)))

;section 2 Span:137..201
;Sakurai S, Oguni S, Hironaka M, Fukayama M, Morinaga S, Saito K.
(SEC
  (FRAG (NNP:[137..144] Sakurai) (NNP:[145..147] S,) (NNP:[148..153] Oguni)
        (NNP:[154..156] S,) (NNP:[157..165] Hironaka) (NNP:[166..168] M,)
        (NNP:[169..177] Fukayama) (NNP:[178..180] M,) (NNP:[181..189] Morinaga)
        (NNP:[190..192] S,) (NNP:[193..198] Saito) (NNP:[199..201] K.)))

;section 3 Span:205..332
;Department of Pathology, Jichi Medical School, Minamikawachi-machi,
;Kawachi-gun,  Tochigi 329-0498, Japan. ssakurai@jichi.ac.jp
(SEC
  (FRAG (NNP:[205..215] Department) (IN:[216..218] of)
        (NNP:[219..228] Pathology) (,:[228..229] ,) (NNP:[230..235] Jichi)
        (NNP:[236..243] Medical) (NNP:[244..250] School) (,:[250..251] ,)
        (NNP:[252..265] Minamikawachi) (::[265..266] -) (NN:[266..271] machi)
        (,:[271..272] ,) (NNP:[273..280] Kawachi) (::[280..281] -)
        (NN:[281..284] gun) (,:[284..285] ,) (NNP:[287..294] Tochigi)
        (CD:[295..298] 329) (::[298..299] -) (CD:[299..303] 0498)
        (,:[303..304] ,) (NNP:[305..310] Japan) (.:[310..311] .)
        ('':[312..326] ssakurai@jichi) (VBD:[326..330] .ac.) (.:[330..332] jp)))

;sentence 4 Span:336..473
;Gain-of-function mutation in c-kit proto-oncogene exon 11 has been described
;in  about 20 -- 50% of gastrointestinal stroma tumor (GIST).
;[353..361]:variation-event:"mutation"
;[365..370]:gene-rna:"c-kit"
;[386..393]:variation-location:"exon 11"
;[436..465]:malignancy:"gastrointestinal stroma tumor"
;[467..471]:malignancy:"GIST"
(SENT
  (S
    (NP-SBJ-1
      (NP
        (NML
          (NML (NN:[336..340] Gain))
          (HYPH:[340..341] -)
          (PP (IN:[341..343] of) (HYPH:[343..344] -)
            (NP (NN:[344..352] function))))
        (NN:[353..361] mutation))
      (PP-LOC (IN:[362..364] in)
        (NP (NN:[365..370] c-kit)
          (NML (AFX:[371..376] proto) (HYPH:[376..377] -)
               (NN:[377..385] oncogene))
           (NN:[386..390] exon) (CD:[391..393] 11))))
    (VP (VBZ:[394..397] has)
      (VP (VBN:[398..402] been)
        (VP (VBN:[403..412] described)
          (NP-1 (-NONE-:[412..412] *))
          (PP (IN:[413..415] in)
            (NP
              (NP
                (QP (RB:[417..422] about) (CD:[423..425] 20)
                    (HYPH:[426..428] --) (CD:[429..431] 50))
                (NN:[431..432] %))
              (PP (IN:[433..435] of)
                (NP
                  (NP (JJ:[436..452] gastrointestinal) (NN:[453..459] stroma)
                      (NN:[460..465] tumor))
                  (NP (-LRB-:[466..467] -LRB-) (NN:[467..471] GIST)
                      (-RRB-:[471..472] -RRB-)))))))))
    (.:[472..473] .)))

;sentence 5 Span:474..770
;Recently, additional  mutational hot-spots in exon 9 and exon 13 of the c-kit
;gene have been reported  in GISTs without mutations of exon 11, but a
;subsequent report in a Western  population indicated that only a small
;portion of GISTs (eight of 200 GISTs, 4%)  showed mutations in these
;regions.
;[520..526]:variation-location:"exon 9"
;[531..538]:variation-location:"exon 13"
;[546..551]:gene-rna:"c-kit"
;[580..585]:malignancy:"GISTs"
;[594..603]:variation-event:"mutations"
;[607..614]:variation-location:"exon 11"
;[704..709]:malignancy:"GISTs"
;[724..729]:malignancy:"GISTs"
;[743..752]:variation-event:"mutations"
(SENT
  (S
    (S
      (ADVP-TMP (RB:[474..482] Recently))
      (,:[482..483] ,)
      (NP-SBJ-1
        (NP (JJ:[484..494] additional) (JJ:[496..506] mutational)
            (JJ:[507..510] hot) (HYPH:[510..511] -) (NNS:[511..516] spots))
        (PP-LOC (IN:[517..519] in)
          (NP
            (NP
              (NP (NN:[520..524] exon) (CD:[525..526] 9))
              (CC:[527..530] and)
              (NP (NN:[531..535] exon) (CD:[536..538] 13)))
            (PP (IN:[539..541] of)
              (NP (DT:[542..545] the) (NN:[546..551] c-kit) (NN:[552..556] gene))))))
      (VP (VBP:[557..561] have)
        (VP (VBN:[562..566] been)
          (VP (VBN:[567..575] reported)
            (NP-1 (-NONE-:[575..575] *))
            (PP-LOC (IN:[577..579] in)
              (NP
                (NP (NNS:[580..585] GISTs))
                (PP (IN:[586..593] without)
                  (NP
                    (NP (NNS:[594..603] mutations))
                    (PP (IN:[604..606] of)
                      (NP (NN:[607..611] exon) (CD:[612..614] 11)))))))))))
    (,:[614..615] ,) (CC:[616..619] but)
    (S
      (NP-SBJ
        (NP (DT:[620..621] a) (JJ:[622..632] subsequent) (NN:[633..639] report))
        (PP (IN:[640..642] in)
          (NP (DT:[643..644] a) (JJ:[645..652] Western)
              (NN:[654..664] population))))
      (VP (VBD:[665..674] indicated)
        (SBAR (IN:[675..679] that)
          (S
            (NP-SBJ
              (NP (RB:[680..684] only) (DT:[685..686] a) (JJ:[687..692] small)
                  (NN:[693..700] portion))
              (PP (IN:[701..703] of)
                (NP (NNS:[704..709] GISTs)
                  (PRN (-LRB-:[710..711] -LRB-)
                    (FRAG
                      (NP
                        (NP (CD:[711..716] eight))
                        (PP (IN:[717..719] of)
                          (NP (CD:[720..723] 200) (NNS:[724..729] GISTs))))
                      (,:[729..730] ,)
                      (NP (CD:[731..732] 4) (NN:[732..733] %)))
                    (-RRB-:[733..734] -RRB-)))))
            (VP (VBD:[736..742] showed)
              (NP
                (NP (NNS:[743..752] mutations))
                (PP-LOC (IN:[753..755] in)
                  (NP (DT:[756..761] these) (NNS:[762..769] regions)))))))))
    (.:[769..770] .)))

;sentence 6 Span:771..1117
;In this study, we evaluated mutations in exon  9 and exon 13 of the c-kit
;gene by both polymerase chain reaction-single strand  conformation
;polymorphism analysis and direct sequencing in 48 GISTs in a  Japanese
;population, for which the clinicopathological and immunohistochemical 
;features and mutations in exon 11 had previously been reported.
;[799..808]:variation-event:"mutations"
;[812..819]:variation-location:"exon  9"
;[824..831]:variation-location:"exon 13"
;[839..844]:gene-rna:"c-kit"
;[858..868]:gene-protein:"polymerase"
;[962..967]:malignancy:"GISTs"
;[1067..1076]:variation-event:"mutations"
;[1080..1087]:variation-location:"exon 11"
(SENT
  (S
    (PP (IN:[771..773] In)
      (NP (DT:[774..778] this) (NN:[779..784] study)))
    (,:[784..785] ,)
    (NP-SBJ (PRP:[786..788] we))
    (VP (VBD:[789..798] evaluated)
      (NP
        (NP (NNS:[799..808] mutations))
        (PP-LOC (IN:[809..811] in)
          (NP
            (NP
              (NP (NN:[812..816] exon) (CD:[818..819] 9))
              (CC:[820..823] and)
              (NP (NN:[824..828] exon) (CD:[829..831] 13)))
            (PP (IN:[832..834] of)
              (NP (DT:[835..838] the) (NN:[839..844] c-kit) (NN:[845..849] gene))))))
      (PP-MNR (IN:[850..852] by)
        (NP (CC:[853..857] both)
          (NP
            (NML
              (NML (NN:[858..868] polymerase) (NN:[869..874] chain)
                   (NN:[875..883] reaction))
              (HYPH:[883..884] -)
              (NML
                (NML (JJ:[884..890] single) (NN:[891..897] strand))
                (NN:[899..911] conformation) (NN:[912..924] polymorphism)))
            (NN:[925..933] analysis))
          (CC:[934..937] and)
          (NP (JJ:[938..944] direct) (NN:[945..955] sequencing))))
      (PP-LOC (IN:[956..958] in)
        (NP
          (NP (CD:[959..961] 48) (NNS:[962..967] GISTs))
          (PP (IN:[968..970] in)
            (NP
              (NP (DT:[971..972] a) (JJ:[974..982] Japanese)
                  (NN:[983..993] population))
              (,:[993..994] ,)
              (SBAR
                (WHPP-3 (IN:[995..998] for)
                  (WHNP (WDT:[999..1004] which)))
                (S
                  (NP-SBJ-2
                    (NP (DT:[1005..1008] the)
                      (NML
                        (NML (JJ:[1009..1028] clinicopathological)
                          (NML-1 (-NONE-:[1028..1028] *P*)))
                        (CC:[1029..1032] and)
                        (NML (JJ:[1033..1052] immunohistochemical)
                          (NML-1 (NNS:[1054..1062] features)))))
                    (CC:[1063..1066] and)
                    (NP
                      (NP (NNS:[1067..1076] mutations))
                      (PP (IN:[1077..1079] in)
                        (NP (NN:[1080..1084] exon) (CD:[1085..1087] 11)))))
                  (VP (VBD:[1088..1091] had)
                    (ADVP-TMP (RB:[1092..1102] previously))
                    (VP (VBN:[1103..1107] been)
                      (VP (VBN:[1108..1116] reported)
                        (NP-2 (-NONE-:[1116..1116] *))
                        (PP-3 (-NONE-:[1116..1116] *T*))))))))))))
    (.:[1116..1117] .)))

;sentence 7 Span:1118..1276
;C-kit gene  mutation in exon 9, representing insertion of GCC TAT, was
;identified in only 4  of 48 GISTs (8%), and none of the GISTs had mutations
;in exon 13.
;[1118..1123]:gene-rna:"C-kit"
;[1130..1138]:variation-event:"mutation"
;[1142..1148]:variation-location:"exon 9"
;[1163..1172]:variation-type:"insertion"
;[1176..1183]:variation-state-generic:"GCC TAT"
;[1217..1222]:malignancy:"GISTs"
;[1245..1250]:malignancy:"GISTs"
;[1255..1264]:variation-event:"mutations"
;[1268..1275]:variation-location:"exon 13"
(SENT
  (S
    (S
      (NP-SBJ-1
        (NP
          (NP (NN:[1118..1123] C-kit) (NN:[1124..1128] gene)
              (NN:[1130..1138] mutation))
          (PP-LOC (IN:[1139..1141] in)
            (NP (NN:[1142..1146] exon) (CD:[1147..1148] 9))))
        (,:[1148..1149] ,)
        (VP (VBG:[1150..1162] representing)
          (NP
            (NP (NN:[1163..1172] insertion))
            (PP (IN:[1173..1175] of)
              (NP (NN:[1176..1179] GCC) (NN:[1180..1183] TAT))))))
      (,:[1183..1184] ,)
      (VP (VBD:[1185..1188] was)
        (VP (VBN:[1189..1199] identified)
          (NP-1 (-NONE-:[1199..1199] *))
          (PP-LOC (IN:[1200..1202] in)
            (NP
              (NP (RB:[1203..1207] only) (CD:[1208..1209] 4))
              (PP (IN:[1211..1213] of)
                (NP (CD:[1214..1216] 48) (NNS:[1217..1222] GISTs)
                  (PRN (-LRB-:[1223..1224] -LRB-)
                    (NP (CD:[1224..1225] 8) (NN:[1225..1226] %))
                    (-RRB-:[1226..1227] -RRB-)))))))))
    (,:[1227..1228] ,) (CC:[1229..1232] and)
    (S
      (NP-SBJ
        (NP (NN:[1233..1237] none))
        (PP (IN:[1238..1240] of)
          (NP (DT:[1241..1244] the) (NNS:[1245..1250] GISTs))))
      (VP (VBD:[1251..1254] had)
        (NP (NNS:[1255..1264] mutations))
        (PP-LOC (IN:[1265..1267] in)
          (NP (NN:[1268..1272] exon) (CD:[1273..1275] 13)))))
    (.:[1275..1276] .)))

;sentence 8 Span:1277..1385
;All four GISTs  with mutation in exon 9 were high-risk, and the patients died
;of multiple tumor  metastasis.
;[1286..1291]:malignancy:"GISTs"
;[1298..1306]:variation-event:"mutation"
;[1310..1316]:variation-location:"exon 9"
;[1367..1384]:malignancy:"tumor  metastasis"
(SENT
  (S
    (S
      (NP-SBJ
        (NP (DT:[1277..1280] All) (CD:[1281..1285] four)
            (NNS:[1286..1291] GISTs))
        (PP (IN:[1293..1297] with)
          (NP
            (NP (NNS:[1298..1306] mutation))
            (PP-LOC (IN:[1307..1309] in)
              (NP (NN:[1310..1314] exon) (CD:[1315..1316] 9))))))
      (VP (VBD:[1317..1321] were)
        (NP-PRD (JJ:[1322..1326] high) (HYPH:[1326..1327] -)
                (NN:[1327..1331] risk))))
    (,:[1331..1332] ,) (CC:[1333..1336] and)
    (S
      (NP-SBJ (DT:[1337..1340] the) (NNS:[1341..1349] patients))
      (VP (VBD:[1350..1354] died)
        (PP-CLR (IN:[1355..1357] of)
          (NP (JJ:[1358..1366] multiple)
             (NN:[1367..1372] tumor) (NN:[1374..1384] metastasis)))))
    (.:[1384..1385] .)))

;sentence 9 Span:1386..1514
;Mutations in exon 9 and exon 13 of the c-kit gene were also rare  events in
;Japanese GISTs and were related to a poor prognosis.
;[1386..1395]:variation-event:"Mutations"
;[1399..1405]:variation-location:"exon 9"
;[1410..1417]:variation-location:"exon 13"
;[1425..1430]:gene-rna:"c-kit"
;[1471..1476]:malignancy:"GISTs"
(SENT
  (S
    (NP-SBJ-1
      (NP (NNS:[1386..1395] Mutations))
      (PP-LOC (IN:[1396..1398] in)
        (NP
          (NP
            (NP (NN:[1399..1403] exon) (CD:[1404..1405] 9))
            (CC:[1406..1409] and)
            (NP (NN:[1410..1414] exon) (CD:[1415..1417] 13)))
          (PP (IN:[1418..1420] of)
            (NP (DT:[1421..1424] the) (NN:[1425..1430] c-kit)
                (NN:[1431..1435] gene))))))
    (VP
      (VP (VBD:[1436..1440] were)
        (ADVP (RB:[1441..1445] also))
        (NP-PRD (JJ:[1446..1450] rare) (NNS:[1452..1458] events))
        (PP-LOC (IN:[1459..1461] in)
          (NP (JJ:[1462..1470] Japanese) (NNS:[1471..1476] GISTs))))
      (CC:[1477..1480] and)
      (VP (VBD:[1481..1485] were)
        (VP (VBN:[1486..1493] related)
          (NP-1 (-NONE-:[1493..1493] *))
          (PP-CLR (TO:[1494..1496] to)
            (NP (DT:[1497..1498] a) (JJ:[1499..1503] poor)
                (NN:[1504..1513] prognosis))))))
    (.:[1513..1514] .)))

;sentence 10 Span:1515..1742
;These results in  Japanese are consistent with those in Western populations,
;although a  preferential occurrence of GISTs with exon 9 mutation in the
;small intestine,  which was suggested in a previous report, was not
;observed.
;[1631..1636]:malignancy:"GISTs"
;[1642..1648]:variation-location:"exon 9"
;[1649..1657]:variation-event:"mutation"
(SENT
  (S
    (NP-SBJ
      (NP (DT:[1515..1520] These) (NNS:[1521..1528] results))
      (PP (IN:[1529..1531] in)
        (NP (JJ:[1533..1541] Japanese))))
    (VP (VBP:[1542..1545] are)
      (ADJP-PRD (JJ:[1546..1556] consistent)
        (PP (IN:[1557..1561] with)
          (NP
            (NP (DT:[1562..1567] those))
            (PP (IN:[1568..1570] in)
              (NP (JJ:[1571..1578] Western) (NNS:[1579..1590] populations))))))
      (,:[1590..1591] ,)
      (SBAR-ADV (IN:[1592..1600] although)
        (S
          (NP-SBJ-2
            (NP
              (NP (DT:[1601..1602] a) (JJ:[1604..1616] preferential)
                  (NN:[1617..1627] occurrence))
              (PP (IN:[1628..1630] of)
                (NP
                  (NP (NNS:[1631..1636] GISTs))
                  (PP (IN:[1637..1641] with)
                    (NP
                      (NP
                        (NML (NN:[1642..1646] exon) (CD:[1647..1648] 9))
                        (NN:[1649..1657] mutation))
                      (PP-LOC (IN:[1658..1660] in)
                        (NP (DT:[1661..1664] the) (JJ:[1665..1670] small)
                            (NN:[1671..1680] intestine))))))))
            (,:[1680..1681] ,)
            (SBAR
              (WHNP-1 (WDT:[1683..1688] which))
              (S
                (NP-SBJ-1 (-NONE-:[1688..1688] *T*))
                (VP (VBD:[1689..1692] was)
                  (VP (VBN:[1693..1702] suggested)
                    (NP-1 (-NONE-:[1702..1702] *))
                    (PP (IN:[1703..1705] in)
                      (NP (DT:[1706..1707] a) (JJ:[1708..1716] previous)
                          (NN:[1717..1723] report))))))))
          (,:[1723..1724] ,)
          (VP (VBD:[1725..1728] was) (RB:[1729..1732] not)
            (VP (VBN:[1733..1741] observed)
              (NP-2 (-NONE-:[1741..1741] *)))))))
    (.:[1741..1742] .)))

;section 11 Span:1746..1791
;PMID: 11376557 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1746..1750] PMID) (::[1750..1751] :) (CD:[1752..1760] 11376557)
        (NN:[1761..1762] -LSB-) (NNP:[1762..1768] PubMed) (::[1769..1770] -)
        (NN:[1771..1778] indexed) (IN:[1779..1782] for)
        (NNP:[1783..1791] MEDLINE-RSB-)))
